THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

AMERICAN CENTURY COMPANIES INC's Holding History (CIK: 0000748054)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 104,294 Value ($000) $1,951 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 95,731 Value ($000) $1,398 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 91,501 Value ($000) $1,009 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 85,707 Value ($000) $765 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 77,931 Value ($000) $733 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 69,642 Value ($000) $561 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 57,611 Value ($000) $489 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 51,585 Value ($000) $463 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 42,877 Value ($000) $482 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 36,123 Value ($000) $312 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 31,482 Value ($000) $326 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 21,204 Value ($000) $228 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 12,698 Value ($000) $142 Avg Close $10.51 Range $9.56 - $11.83
Q3 2017
Shares 28,279 Value ($000) $968 Avg Close $32.70 Range $23.15 - $42.61
Q2 2017
Shares 28,081 Value ($000) $1,119 Avg Close $38.45 Range $34.85 - $43.44
Q1 2017
Shares 30,753 Value ($000) $1,132 Avg Close $31.95 Range $27.80 - $37.18